Financhill
Back

Neumora Therapeutics Stock Predictions

Neumora Therapeutics Stock Forecast

  • Is Neumora Therapeutics Stock Undervalued?
    The current Neumora Therapeutics [NMRA] share price is $10.32. The Score for NMRA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • NMRA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Neumora Therapeutics Stock Go Up Next Year?

Data Unavailable

Neumora Therapeutics Stock Rating

Data Unavailable

Neumora Therapeutics Stock Price History

Is NMRA stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
neumoratx.com

52-Week Data

52-Week High:
21.00
52-Week Low:
8.33

Prediction Charts

Market Cap:
1.67B
Price in USD:
10.32
Volume:
859.23K
Beta:
2.70

Technical Analysis

SMA50:
12.13
SMA100:
12.07
SMA200:
11.78
52-Wk Change:
-27.58%

Stock Predictions

  • Is Neumora Therapeutics stock public?
    Yes, Neumora Therapeutics is a publicly traded company.
  • What is the Neumora Therapeutics stock quote today?
    The Neumora Therapeutics stock price is 10.32 USD today.
  • How to buy Neumora Therapeutics stock online?
    You can buy Neumora Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-25 9.77 9.67 9.97 9.61
Nov-26 9.65 9.77 9.92 9.58
Nov-27 9.74 9.76 9.97 9.64
Nov-29 9.84 9.94 10.13 9.70
Dec-2 9.88 9.80 10.02 9.63
Dec-3 9.75 9.67 9.84 9.59
Dec-4 9.60 9.77 10.00 9.38
Dec-5 9.73 9.66 10.00 9.63
Dec-6 9.72 10.29 10.77 9.66
Dec-9 10.31 10.37 10.54 10.07
Dec-10 10.33 10.39 10.68 10.20
Dec-11 10.84 10.52 10.84 10.06
Dec-12 10.46 10.58 10.61 10.11
Dec-13 10.63 10.32 10.80 10.08

Neumora Therapeutics Earnings

Data Unavailable

Neumora Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and a decrease next year of $0.07 per share.

* Neumora Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.